September 04, 2020
Cocrystal Pharma Inc. will implement a series of corporate reforms to settle three derivative suits brought by shareholders over an alleged $27 million pump-and-dump scheme that drove down the value of the company's stock, according to a motion Friday in New Jersey federal court seeking preliminary approval of the deal.
June 08, 2020
Settlement talks are underway in a derivative suit brought by Cocrystal Pharma Inc. shareholders over a $27 million pump-and-dump scheme that purportedly drove down the value of the company's stock, according to a New Jersey federal court filing Monday.
August 16, 2019
Shareholders of BioZone Pharmaceuticals Inc.'s successor slammed its former executives and high-profile investors with a lawsuit Thursday alleging they ensnared the company in a $27 million pump-and-dump scheme that drove down the value of its stock.